How can we teach our children if we cannot access the forest? Generational change in Mapuche knowledge of wild edible plants in Andean temperate ecosystems of Chile

For many indigenous peoples, the contributions of wild edible plants go well beyond nourishment; they are often also used as dye and medicines, as well as markers of identity. However, historical and contemporary processes of land grabbing, forest loss, acculturation, and lifestyle changes may Erode the transmission of plant knowledge to new generations. In this paper, we document 1) the botanical knowledge of wild edible plants and 2) perceived influences on the transmission of this knowledge to younger generations in a Mapuche community in Andean temperate forests, Chile. Thirty-seven people participated in this study. We conducted participant observation, freelists, and informal, photo-elicitation, and semi-structured interviews. A total of 47 wild edibles were recorded (42 plants were determined to species level by participants). Digüeñe (Cyttaria espinosae; Smith's Index of Saliency, S = 0.82) was the most salient wild edible, followed by changle (Ramaria flava, S = 0.68), maqui (Aristotelia chilensis, S = 0.67), murra (Rubus ulmifolius, S = 0.59), and piñón (Araucaria araucana, S = 0.56). Participants provided detailed information on species seasonality, ecology, and changes in availability over time. Most adult women and elders had a comprehensive knowledge of wild edibles. However, younger generations were not learning what the elders had once learned. The lack of access to forests and the formal school regime were reported as the main factors interrupting the transmission of knowledge. Because Mapuche pedagogy is oral and in situ, land loss and the school regime have left younger generations with few opportunities to engage in these forms of indigenous pedagogy

How can we teach our children if we cannot access the forest? Generational change in Mapuche knowledge of wild edible plants in Andean temperate ecosystems of Chile

For many indigenous peoples, the contributions of wild edible plants go well beyond nourishment; they are often also used as dye and medicines, as well as markers of identity. However, historical and contemporary processes of land grabbing, forest loss, acculturation, and lifestyle changes may Erode the transmission of plant knowledge to new generations. In this paper, we document 1) the botanical knowledge of wild edible plants and 2) perceived influences on the transmission of this knowledge to younger generations in a Mapuche community in Andean temperate forests, Chile. Thirty-seven people participated in this study. We conducted participant observation, freelists, and informal, photo-elicitation, and semi-structured interviews. A total of 47 wild edibles were recorded (42 plants were determined to species level by participants). Digüeñe (Cyttaria espinosae; Smith's Index of Saliency, S = 0.82) was the most salient wild edible, followed by changle (Ramaria flava, S = 0.68), maqui (Aristotelia chilensis, S = 0.67), murra (Rubus ulmifolius, S = 0.59), and piñón (Araucaria araucana, S = 0.56). Participants provided detailed information on species seasonality, ecology, and changes in availability over time. Most adult women and elders had a comprehensive knowledge of wild edibles. However, younger generations were not learning what the elders had once learned. The lack of access to forests and the formal school regime were reported as the main factors interrupting the transmission of knowledge. Because Mapuche pedagogy is oral and in situ, land loss and the school regime have left younger generations with few opportunities to engage in these forms of indigenous pedagogy

Circulating Serum Free Light Chains As Predictive Markers of AIDS-Related Lymphoma

Purpose HIV-infected persons have an elevated risk of developing non-Hodgkin's lymphoma (NHL); this risk remains increased in the era of effective HIV therapy. We evaluated serum immunoglobulin (Ig) proteins as predictors of NHL risk among HIV-infected individuals. Patients and Methods By using three cohorts of HIV-infected persons (from 1982 to 2005), we identified 66 individuals who developed NHL and 225 matched (by cohort, sex, ethnicity, age, and CD4 count), HIV-infected, lymphoma-free controls who had available stored prediagnostic blood samples. Serum/plasma samples obtained 0 to 2 years and 2 to 5 years before diagnosis/selection were assayed for IgG, IgM, and IgA levels; monoclonal (M) Igs; and κ and λ free light chain (FLC) levels. Patients and matched controls were compared by using conditional logistic regression. Results The κ and λ FLCs were both significantly higher in patients (eg, in 2- to 5-year window: median κ, 4.24 v 3.43 mg/dL; median λ, 4.04 v 3.09 mg/dL) and strongly predicted NHL in a dose-response manner up to 2 to 5 years before diagnosis/selection (eg, NHL risk 3.76-fold higher with κ concentration at least 2.00 times the upper limit of normal, and 8.13-fold higher with λ concentration at least 2.00 times the upper limit of normal compared with normal levels). In contrast, IgG, IgM, and IgA levels were similar in patients and controls. M proteins were detected in only two patients with NHL (3%) and in nine controls (4%), and they were not significantly associated with NHL risk. Conclusion Elevated FLCs may represent sensitive markers of polyclonal B-cell activation and dysfunction and could be useful for identifying HIV-infected persons at increased NHL risk

Emerging therapeutic paradigms to target the dysregulated Janus kinase/signal transducer and activator of transcription pathway in hematological malignancies

Over the past decade, there has been increasing biochemical evidence that the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway is aberrantly activated in malignant cells from patients with a wide spectrum of cancers of the blood and immune systems. The emerging availability of small molecule inhibitors of JAK and other signaling molecules in the JAK/STAT pathway has allowed preclinical studies validating an important role of this pathway in the pathogenesis of many hematologic malignancies, and provided motivation for new strategies for treatment of these diseases. Here, a round-table panel of experts review the current preclinical and clinical landscape of the JAK/STAT pathway in acute lymphoid and myeloid leukemias, lymphomas and myeloma, and chronic myeloid neoplasms